Clinical Trials Update: June 9, 2005
Depression (Major/Severe) Anemia Schizophrenia and Schizoaffective Disorders
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
This is an eight-week research study of an investigational drug for patients with major depressive disorder. Patients must be 18-64 years of age and must have a diagnosis of major depressive disorder. Research site located in Redlands, Calif.
Have you been told you have anemia? You may qualify for a new clinical research study if you are at least 65 years of age, you have had no active cancer or cancer therapy within the last 12 months, you would be willing to visit the office as required and you would be willing to take investigational drug as directed by a doctor. Research site located in Warner Robins, Ga.
Schizophrenia and Schizoaffective Disorders
The purpose of this study is to compare an investigational agent to a marketed medication in the treatment of people with negative symptoms of schizophrenia. Patients completing this study may be eligible to participate in an additional study and receive an additional six months of treatment. Participants must be men or women at least 18 years of age, have a current primary diagnosis of negative symptoms of schizophrenia, and have been clinically stable for the past five months. Research site located in Oak Brook, Ill.
Copyright 2005 CenterWatch. All rights reserved.